Mercifully, I have been free of PMR since last Christmas and taking tablets just every second morning is a blessing. I thought this study interesting: rheumatologyadvisor.com/hom...
In particular:
Pooled prevalence was 20% in patients with PMR whose subclinical GCA was diagnosed by biopsy (CI, 7%-46%, I2=86%), 15% by ultrasonography (CI, 3%-50%, I2=86%), and 29% by PET/CT scans (CI, 13%-53%, I2=85%). The combined pooled prevalence of subclinical GCA in patients newly diagnosed with PMR was 23% (CI, 14%-36%, I2=84%).
Inflammatory back pain, lack of lower extremity pain, female sex, body temperature over 37.0°C, weight loss, thrombocyte count, and hemoglobin levels strongly predicted development of subclinical GCA. Conversely, C-reactive protein levels, erythrocyte sedimentation rate, leukocyte count, age, neck pain, pelvic girdle pain, and duration of morning stiffness did not predict development of subclinical GCA.
Written by
Joydeck
To view profiles and participate in discussions please or .
The figure I have always registered was about 1 in 5 - and as the article says, those studies were often on a selected population - the PMR patients sent to a specialist rather than those who remain with their PCP.
It's a shame that PET-CT is so expensive and hard to access - in fact, not even sure a GP could refer for one even if there was better access/shorter waiting lists. A PET-CT done on every putative PMR patient before they get even 1 tablet of pred would be a fantastic way to go ...
Agreed. I’ve shared this before. A study done using PET scans catching sub clinical GCA/LVV. Also shows the advantage of Actemra with this. This was the tipping point that had me decide to start Actemra and I’m very glad I did!
Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.
Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.